CURE.DE vs. QUTM.DE
CURE.DE (VanEck Genomics and Healthcare Innovators UCITS ETF A) and QUTM.DE (VanEck Quantum Computing UCITS ETF A USD Acc) are both exchange-traded funds - CURE.DE is a Health & Biotech Equities fund tracking the MVIS Global Future Healthcare ESG, while QUTM.DE is a Technology Equities fund tracking the MarketVector™ Global Quantum Leaders Total Return Net Index (MVQTMLTR). Both are passively managed. Over the past year, CURE.DE returned 14.68% vs 49.47% for QUTM.DE. At a 0.36 correlation, their price movements are largely independent. CURE.DE charges 0.35%/yr vs 0.55%/yr for QUTM.DE.
Performance
CURE.DE vs. QUTM.DE - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, CURE.DE achieves a 0.01% return, which is significantly lower than QUTM.DE's 23.86% return.
CURE.DE
- 1D
- 0.00%
- 1M
- 11.67%
- YTD
- 0.01%
- 6M
- -0.48%
- 1Y
- 14.68%
- 3Y*
- -0.09%
- 5Y*
- —
- 10Y*
- —
QUTM.DE
- 1D
- -1.33%
- 1M
- -5.99%
- YTD
- 23.86%
- 6M
- 22.33%
- 1Y
- 49.47%
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
CURE.DE vs. QUTM.DE - Yearly Performance Comparison
| 2026 (YTD) | 2025 | |
|---|---|---|
CURE.DE VanEck Genomics and Healthcare Innovators UCITS ETF A | 0.01% | 16.27% |
QUTM.DE VanEck Quantum Computing UCITS ETF A USD Acc | 23.86% | 14.27% |
Correlation
The correlation between CURE.DE and QUTM.DE is 0.35, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.35 |
Correlation (All Time) Calculated using the full available price history since May 26, 2025 | 0.36 |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
CURE.DE vs. QUTM.DE — Risk / Return Rank
CURE.DE
QUTM.DE
CURE.DE vs. QUTM.DE - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for VanEck Genomics and Healthcare Innovators UCITS ETF A (CURE.DE) and VanEck Quantum Computing UCITS ETF A USD Acc (QUTM.DE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| CURE.DE | QUTM.DE | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.74 | ||
| Sortino ratioReturn per unit of downside risk | -0.82 | ||
| Omega ratioGain probability vs. loss probability | 1.13 | 1.25 | -0.11 |
| Calmar ratioReturn relative to maximum drawdown | 0.77 | 1.99 | -1.21 |
| Martin ratioReturn relative to average drawdown | 1.66 | 4.79 | -3.14 |
Loading charts...
Drawdowns
CURE.DE vs. QUTM.DE - Drawdown Comparison
The maximum CURE.DE drawdown since its inception was -34.80%, which is greater than QUTM.DE's maximum drawdown of -24.77%. Use the drawdown chart below to compare losses from any high point for CURE.DE and QUTM.DE.
Loading charts...
Drawdown Indicators
| CURE.DE | QUTM.DE | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -34.80% | -24.77% | -10.03% |
Max Drawdown (1Y)Largest decline over 1 year | -19.07% | -24.77% | +5.70% |
Max Drawdown (3Y)Largest decline over 3 years | -29.29% | — | — |
Current DrawdownCurrent decline from peak | -11.12% | -11.10% | -0.02% |
Average DrawdownAverage peak-to-trough decline | -15.12% | -7.79% | -7.33% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 8.87% | 10.29% | -1.42% |
Volatility
CURE.DE vs. QUTM.DE - Volatility Comparison
The current volatility for VanEck Genomics and Healthcare Innovators UCITS ETF A (CURE.DE) is 7.10%, while VanEck Quantum Computing UCITS ETF A USD Acc (QUTM.DE) has a volatility of 12.75%. This indicates that CURE.DE experiences smaller price fluctuations and is considered to be less risky than QUTM.DE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| CURE.DE | QUTM.DE | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 7.10% | 12.75% | -5.65% |
Volatility (6M)Calculated over the trailing 6-month period | 15.59% | 24.53% | -8.94% |
Volatility (1Y)Calculated over the trailing 1-year period | 20.41% | 33.64% | -13.23% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 20.75% | 33.19% | -12.44% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 20.75% | 33.19% | -12.44% |
CURE.DE vs. QUTM.DE - Expense Ratio Comparison
CURE.DE has a 0.35% expense ratio, which is lower than QUTM.DE's 0.55% expense ratio.
Dividends
CURE.DE vs. QUTM.DE - Dividend Comparison
Neither CURE.DE nor QUTM.DE has paid dividends to shareholders.
Frequently Asked Questions
CURE.DE and QUTM.DE have a correlation of 0.35, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
On fees, CURE.DE is cheaper at 0.35% per year. The better choice depends on whether you care most about return, fees, risk, or income.
CURE.DE is cheaper with a 0.35% expense ratio, compared with 0.55% for QUTM.DE.
CURE.DE is categorized as Health & Biotech Equities, while QUTM.DE is Technology Equities. CURE.DE tracks MVIS Global Future Healthcare ESG, while QUTM.DE tracks MarketVector™ Global Quantum Leaders Total Return Net Index (MVQTMLTR). Their fees differ too: 0.35% for CURE.DE and 0.55% for QUTM.DE.
Find the right allocation for CURE.DE and QUTM.DE
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer